Clinical trial
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid…
NCT00049582 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00049582 |
|---|---|
| Title | Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia |
| Official title | Phase I Study of 5-Aza-2'-Deoxycytidine (Decitabine) as a Biologic Modifier of Retinoid Responsive Genes in Patients With High-Risk Myelodysplastic Syndromes and Acute Myelogenous Leukemia (De-novo, Relapsed or Secondary) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13, q22), Adult Acute Myeloid Leukemia With t(15, 17)(q22, q12), Adult Acute Myeloid Leukemia With t(16, 16)(p13, Adult Acute Myeloid Leukemia With t(8, 21)(q22 and 10 more |
| Intervention type | Drug, Other |
| Interventions | decitabine, laboratory biomarker analysis, pharmacological study |
| Enrollment | 36 |
| Start date | Sep 1, 2002 |
| Primary completion | Jun 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 30, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: